Unknown

Dataset Information

0

SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage.


ABSTRACT: Rheumatoid arthritis (RA) is the most common arthritis and is mainly characterized by symmetric polyarticular joint disorders. Our previous study demonstrated a novel small molecule compound (Z)-N-(3-Chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene) methyl) phenoxy) acet-amide (SKLB023) showed potently anti-arthritic effects in a rat arthritis model, however, the underlying mechanisms for this are largely unknown. Both NF-?B and macrophages were reported to play important roles in the pathologic processes of RA. The purposes of this study were to indicate whether NF-?B and macrophages contributed to anti-arthritic effects of SKLB023 in two experimental arthritis models. Our results showed that SKLB023 could significantly improve joint inflammation and cartilage destruction both in adjuvant induced arthritis (AIA) and collagen-induced arthritis (CIA) models. We further found that the binding activation of NF-?B to DNA in joint tissues and RAW264.7 macrophages were suppressed by SKLB023. SKLB023 also inhibited the NF-?B activity in peritoneal macrophages by luciferase assay. Furthermore, the number of macrophages in synovial tissues was decreased after the treatment of different doses of SKLB023. The levels of TNF-?, IL-1?, and IL-6 in plasma, and the levels of TNF-?, NO, and IL-1? in peritoneal macrophages were down-regulated by SKLB023. Finally, SKLB023 attenuated the expression of iNOS and COX-2 in vivo and suppressed the phosphorylations of components of the mitogen-activated protein kinases (MAPKs). These observations identify a novel function for SKLB023 as an inhibitor of NF-?B in macrophages of RA, highlighting that SKLB023 was a potential therapeutic strategy for RA.

SUBMITTER: Xie C 

PROVIDER: S-EPMC3576337 | biostudies-other | 2013

REPOSITORIES: biostudies-other

altmetric image

Publications

SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage.

Xie Caifeng C   Ma Liang L   Liu Juan J   Li Xiuxia X   Pei Heying H   Xiang Mingli M   Chen Lijuan L  

PloS one 20130219 2


Rheumatoid arthritis (RA) is the most common arthritis and is mainly characterized by symmetric polyarticular joint disorders. Our previous study demonstrated a novel small molecule compound (Z)-N-(3-Chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene) methyl) phenoxy) acet-amide (SKLB023) showed potently anti-arthritic effects in a rat arthritis model, however, the underlying mechanisms for this are largely unknown. Both NF-κB and macrophages were reported to play important roles in the patholo  ...[more]

Similar Datasets

| S-EPMC5913847 | biostudies-other
| S-EPMC7245816 | biostudies-literature
| S-EPMC3978700 | biostudies-literature
| S-EPMC4107547 | biostudies-literature
| S-EPMC5398531 | biostudies-literature
| S-EPMC6446600 | biostudies-literature
| S-EPMC3143151 | biostudies-literature
| S-EPMC5853033 | biostudies-literature
| S-EPMC6091035 | biostudies-literature
| S-EPMC5386999 | biostudies-literature